SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
25.78
-0.42 (-1.60%)
Aug 17, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Employees
SpyGlass Pharma had 76 employees as of June 30, 2026.
Employees
76
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$737,539
Market Cap
862.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 76 | - | - |
| Mar 31, 2026 | 68 | - | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Olema Pharmaceuticals | 150 |
| Theravance Biopharma | 90 |
| Silence Therapeutics | 88 |
| Aclaris Therapeutics | 73 |
| Candel Therapeutics | 55 |
| Design Therapeutics | 55 |
| Faeth Therapeutics | 29 |
SGP News
- 1 day ago - SpyGlass Pharma initiated with an Outperform at Raymond James - TheFly
- 11 days ago - SpyGlass Pharma reports Q2 EPS (59c), consensus (55c) - TheFly
- 11 days ago - SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 11 days ago - SpyGlass Pharma Earnings release: Q2 2026 - Filings
- 11 days ago - SpyGlass Pharma Quarterly report: Q2 2026 - Filings
- 2 months ago - SpyGlass Pharma Appoints Shannon Treviño as General Counsel - GlobeNewsWire
- 2 months ago - SpyGlass Pharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - SpyGlass Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts